Skip to main content
Frontiers in Molecular Biosciences logoLink to Frontiers in Molecular Biosciences
. 2021 Dec 22;8:826905. doi: 10.3389/fmolb.2021.826905

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Xiaoyu Zhang 1, Xiaoqin He 1, Yue Li 1, Yangtao Xu 1, Wenliang Chen 1, Xin Liu 1, Xinyao Hu 1, Lin Xiong 2, Ximing Xu 1,*
PMCID: PMC8727543  PMID: 35004862

In the published article, incorrect affiliation was included for Xiaoyu Zhang 1 , Xiaoqin He 1 , Yue Li 1 , Yangtao Xu 1 , Wenliang Chen 1 , Xin Liu 1 , Xinyao Hu 1 , Ximing Xu 1 . Instead of “1Wuhan University, Wuhan, China” it should be 1 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China. In addition, incorrect affiliation was included for Lin Xiong 2 . Instead of “2Renmin Hospital of Wuhan University, Wuhan, China” it should be 2 Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Molecular Biosciences are provided here courtesy of Frontiers Media SA

RESOURCES